Analysts at UBS and Jefferies found a lot to like in the Street-beating Q2 results out of Medtronic (NYSE:MDT). “Commentary was encouraging on many fronts. COVID is raging, but hospitals are coping better this time, and MDT still expects to see normalized growth by 4Q. The bigger story is the new tone under CEO Geoff Martha. […]
Featured
Zimmer Biomet could pay millions after two hip implant lawsuit losses
A federal judge in Missouri has signed off on a $21 million judgment against Zimmer Biomet (NYSE:ZBH) involving the company’s much-litigated M2a Magnum metal-on-metal hip implant. U.S. District Judge Stephen R. Clark’s sign-off yesterday of the award — $20 million to Mary Bayes and $1 million to her husband Philip Bayes — came a day […]
U.S. plans to ship 6.4M COVID-19 vaccine doses to states in mid-December
About 6.4 million doses of the COVID-19 vaccine from Pfizer (NYSE:PFE) and its partner BioNTech (NSDQ:BNTX) will ship to U.S. states in mid-December, as long as the vaccine soon receives an FDA EUA. There are also plans to quickly distribute vaccine from rival COVID-19 vaccine developer Moderna (NSDQ:MRNA), which could soon apply for an EUA, officials at the federal […]
FDA authorizes Kantaro’s ‘high performance’ COVID-19 antibody test
Kantaro Biosciences announced today that it received FDA emergency use authorization (EUA) for its COVID-SeroKlir antibody test. New York-based Kantaro, a joint venture between Mount Sinai Health System and RenalytixAI (NSDQ:RNLX), developed the semi-quantitative SARS-CoV-2 IgG antibody test kit to determine the presence and precise level of IgG antibodies related to COVID-19. A partnership with […]
HHS confirms involvement in presidential transition process
U.S. Health and Human Services Dept. Secretary Alex Azar confirmed that HHS is working with president-elect Joe Biden on a presidential transition. Speaking during a press briefing, Azar said HHS is in contact with the transition team after the General Services Administration formally recognized Biden as the president-elect, having previously sidestepped questions regarding the potential […]
Exactech to distribute Bodycad’s Reflex Uni knee
Exactech announced today that it has signed an agreement to be the exclusive U.S. distributor of Bodycad‘s Reflex Uni knee. The Reflex Uni expands Exactech’s Truliant primary and revision knee system to include a personalized unicompartmental implant, designed to fit each person’s unique anatomy. Exactech is touting the Truliant Reflex Uni as the latest addition […]
Who would — and wouldn’t — line up for COVID-19 vaccines?
Once enough people receive effective vaccines against the novel coronavirus, experts say, the end of the pandemic may be in sight. But a new poll of older adults — one of the highest-priority groups for vaccination — suggests an uphill climb lies ahead to reach that goal. In all, 58% of adults aged 50 to […]
Regeneron antibody cocktail wins emergency use authorization
Regeneron Pharmaceuticals (NSDQ:REGN) has announced that the FDA has granted emergency use authorization (EUA) for the combination of casirivimab and imdevimab to treat COVID-19. The monoclonal antibody cocktail is reportedly the first treatment to show “statistically significant anti-viral activity” against COVID-19, according to its developer. In a trial, the combination of drugs cut hospitalization or emergency […]
Medtronic rises on Street-beating Q2 driven by ventilator sales
Medtronic (NYSE:MDT) shares ticked up before hours today on second-quarter results that topped the consensus forecast. The Fridley, Minn.-based company posted profits of $494 million, or 36¢ per share, on sales of $7.6 billion for the three months ended Oct. 30, 2020, for a -64% bottom-line slide on a sales decline of 0.8%. Adjusted to exclude […]
Butterfly Network to go public via merger
Butterfly Network announced that it entered into a definitive business combination agreement and will go public with Longview Acquisition Corp. Upon the closing of the deal between Butterfly, a medical imaging technology developer, and Longview, a special purpose acquisition company, the combined company’s Class A common stock is expected to be traded on the New […]
MDMA’s Leahey says two-party control can benefit medtech
Splitting party control over the White House and Congress may concern some, but this dynamic has worked well for the medtech industry in the past, according to Mark Leahey, president of the Medical Device Manufacturers Association. In an interview in this week’s DeviceTalks Weekly Podcast, Leahey said the industry sees long-lasting benefits when both parties […]
